Patents by Inventor Peter Lars Aksel BERGLUND

Peter Lars Aksel BERGLUND has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions comprising lentiviral vectors expressing IL-12 and methods of use thereof
    Patent number: 11365230
    Abstract: This patent application relates generally to the treatment of cancer, and more particularly to the use of a pseudotyped lentivirus expressing IL-12 for the treatment of cancer.
    Type: Grant
    Filed: November 8, 2016
    Date of Patent: June 21, 2022
    Assignee: IMMUNE DESIGN CORP.
    Inventors: Jan Henrik Ter Meulen, Peter Lars Aksel Berglund, Tinglan Tina Albershardt
  • RETROVIRAL VECTOR FOR THE ADMINISTRATION AND EXPRESSION OF REPLICON RNA EXPRESSING HETEROLOGOUS NUCLEIC ACIDS
    Publication number: 20220088177
    Abstract: The present disclosure relates generally to gene delivery using a chimeric, retroviral-RNA replicon vector particle for increased expression of transgenes in a host cell. In particular, the chimeric vectors described herein can be used in any of a variety of settings including gene therapy and vaccine settings.
    Type: Application
    Filed: September 3, 2021
    Publication date: March 24, 2022
    Applicant: Immune Design Corp.
    Inventors: Peter Lars Aksel Berglund, Jacob Freeman Archer, Tsai-yu Lin
  • RETROVIRAL VECTOR FOR THE ADMINISTRATION AND EXPRESSION OF REPLICON RNA EXPRESSING HETEROLOGOUS NUCLEIC ACIDS
    Publication number: 20220054627
    Abstract: The present disclosure relates generally to gene delivery using a chimeric, retroviral-RNA replicon vector particle for increased expression of transgenes in a host cell. In particular, the chimeric vectors described herein can be used in any of a variety of settings including gene therapy and vaccine settings.
    Type: Application
    Filed: September 3, 2021
    Publication date: February 24, 2022
    Applicant: Immune Design Corp.
    Inventors: Peter Lars Aksel Berglund, Jacob Freeman Archer, Tsai-yu Lin
  • PATHOGEN-ASSOCIATED MOLECULAR PATTERN MOLECULES AND RNA IMMUNOGENIC COMPOSITIONS AND METHODS OF USING THE COMPOSITIONS FOR TREATING CANCER
    Publication number: 20220054611
    Abstract: The present invention provides novel compositions and methods for inhibiting tumor growth, treating cancer, and/or inducing immune responses. Such compositions and methods induce an immune response for the treatment of a variety of diseases including cancer.
    Type: Application
    Filed: December 16, 2019
    Publication date: February 24, 2022
    Applicant: IMMUNE DESIGN CORP.
    Inventors: Peter Lars Aksel Berglund, Tinglan Tina Albershardt, Jan Henrik Ter Meulen, Jardin Alexandra Leleux
  • Retroviral vector for the administration and expression of replicon RNA expressing heterologous nucleic acids
    Patent number: 11135283
    Abstract: The present disclosure relates generally to gene delivery using a chimeric, retroviral-RNA replicon vector particle for increased expression of transgenes in a host cell. In particular, the chimeric vectors described herein can be used in any of a variety of settings including gene therapy and vaccine settings.
    Type: Grant
    Filed: November 9, 2016
    Date of Patent: October 5, 2021
    Assignee: Immune Design Corp.
    Inventors: Peter Lars Aksel Berglund, Jacob Freeman Archer, Tsai-Yu Lin
  • A RETROVIRAL VECTOR FOR THE ADMINISTRATION AND EXPRESSION OF REPLICON RNA EXPRESSING HETEROLOGOUS NUCLEIC ACIDS
    Publication number: 20200254087
    Abstract: The present disclosure relates generally to gene delivery using a chimeric, retroviral-RNA replicon vector particle for increased expression of transgenes in a host cell. In particular, the chimeric vectors described herein can be used in any of a variety of settings including gene therapy and vaccine settings.
    Type: Application
    Filed: November 9, 2016
    Publication date: August 13, 2020
    Inventors: Peter Lars Aksel Berglund, Jacob Freeman Archer, Tsai-Yu Lin
  • Multigenome retroviral vector preparations and methods and systems for producing and using same
    Patent number: 10584356
    Abstract: The present invention provides novel multigenome retroviral vectors, methods and packaging systems for making such retroviral vectors and methods of use.
    Type: Grant
    Filed: December 6, 2018
    Date of Patent: March 10, 2020
    Assignee: IMMUNE DESIGN CORP.
    Inventors: Jan Henrik Ter Meulen, Peter Lars Aksel Berglund
  • COMPOSITIONS COMPRISING LENTIVIRAL VECTORS EXPRESSING IL-12 AND METHODS OF USE THEREOF
    Publication number: 20190375811
    Abstract: This patent application relates generally to the treatment of cancer, and more particularly to the use of a pseudotyped lentivirus expressing IL-12 for the treatment of cancer.
    Type: Application
    Filed: November 8, 2016
    Publication date: December 12, 2019
    Inventors: Jan Henrik Ter Meulen, Peter Lars Aksel Berglund, Tinglan Tina Albershardt
  • MULTIGENOME RETROVIRAL VECTOR PREPARATIONS AND METHODS AND SYSTEMS FOR PRODUCING AND USING SAME
    Publication number: 20190127759
    Abstract: The present invention provides novel multigenome retroviral vectors, methods and packaging systems for making such retroviral vectors and methods of use.
    Type: Application
    Filed: December 6, 2018
    Publication date: May 2, 2019
    Applicant: IMMUNE DESIGN CORP.
    Inventors: Jan Henrik Ter Meulen, Peter Lars Aksel Berglund
  • Multigenome retroviral vector preparations and methods and systems for producing and using same
    Patent number: 10179919
    Abstract: The present invention provides novel multigenome retroviral vectors, methods and packaging systems for making such retroviral vectors and methods of use.
    Type: Grant
    Filed: February 22, 2017
    Date of Patent: January 15, 2019
    Assignee: IMMUNE DESIGN CORP.
    Inventors: Jan Henrik Ter Meulen, Peter Lars Aksel Berglund
  • MULTIGENOME RETROVIRAL VECTOR PREPARATIONS AND METHODS AND SYSTEMS FOR PRODUCING AND USING SAME
    Publication number: 20170268020
    Abstract: The present invention provides novel multigenome retroviral vectors, methods and packaging systems for making such retroviral vectors and methods of use.
    Type: Application
    Filed: February 22, 2017
    Publication date: September 21, 2017
    Applicant: IMMUNE DESIGN CORP.
    Inventors: Jan Henrik Ter Meulen, Peter Lars Aksel Berglund
  • PRIME-BOOST REGIMENS WITH A TLR4 AGONIST ADJUVANT AND A LENTIVIRAL VECTOR
    Publication number: 20170196954
    Abstract: Compositions and methods are provided herein for improved dual immunization strategies that induce in a subject a robust immune response. The methods described are therefore useful for treating and/or preventing (i.e., reducing the likelihood or risk of occurrence) different diseases, disorders, and conditions such as cancers and infectious diseases for which induction of a humoral immune response and/or cellular immune response is desired and beneficial.
    Type: Application
    Filed: July 14, 2015
    Publication date: July 13, 2017
    Inventors: Richard KENNEY, Frank HSU, Jan Henrik TER MEULEN, Peter Lars Aksel BERGLUND